Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Advanced Metastatic Gastric Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 379 Breast Neoplasms 362 Colorectal Neoplasms 235 Stomach Neoplasms 216 Carcinoma, Hepatocellular 155 Lung Neoplasms 122 Neoplasms 120 Pancreatic Neoplasms 105 Prostatic Neoplasms 96 Neoplasm Metastasis 96 Recurrence 94 Rectal Neoplasms 93 Ovarian Neoplasms 91 Nasopharyngeal Carcinoma 88 Esophageal Squamous Cell Carcinoma 80 Esophageal Neoplasms 80 Lymphoma, Large B-Cell, Diffuse 79 Melanoma 75 Small Cell Lung Carcinoma 71 Lymphoma 70 Leukemia, Myeloid, Acute 70 Uterine Cervical Neoplasms 69 Head and Neck Neoplasms 69 Brain Neoplasms 69 Sarcoma 68 Squamous Cell Carcinoma of Head and Neck 67 Multiple Myeloma 65 Carcinoma, Renal Cell 62 Triple Negative Breast Neoplasms 59 Lymphoma, Non-Hodgkin 55

Interventions

sintilimab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04089657 2019-09-13

ASGARD

Fujian Cancer Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Metastatic Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡